In power from 1996 to 1999 and again since 2009, Netanyahu has acquired a reputation as a master political survivor.JERUSALEM: Israeli Prime Minister Benjamin Netanyahu’s mandate to form a government following an inconclusive election expired on Wednesday, giving his rivals a chance to take power and end the divisive premier’s record tenure. Netanyahu, on trial over corruption charges he denies, had a 28-day window to secure a coalition following the March 23 vote, Israel’s fourth in less than two years. The 71-year-old’s right-wing Likud party won the most seats in the vote, but he and his allies came up short of an absolute majority in the 120-seat Knesset, Israel’s parliament. The results delivered by a deeply fractured electorate left Netanyahu with a daunting path towards 61 seats, as voters broadly chose not to reward him for a successful coronavirus vaccination campaign. President Reuven Rivlin’s office said in a statement that Netanyahu had “informed (the presidency) that he was unable to form a government and so returned the mandate to the president.” In power from 1996 to 1999 and again since 2009, Netanyahu has acquired a reputation as a master political survivor and Israeli media had over the past four weeks feverishly speculated about deals he was hatching to stay in power. But the obstacles that faced Netanyahu the morning after the vote remained largely unchanged. A Netanyahu-led coalition likely would have required tacit cooperation between the conservative Islamic Raam party and the far-right Religious Zionism alliance, whose leaders have hurled incendiary anti-Arab rhetoric during their political careers. Raam’s leader Mansour Abbas had said he was open to any arrangement that improved living standards for Israel’s 20 percent Arab minority. But Religious Zionism’s leader Bezalel Smotrich has repeatedly called Raam “terror supporters” who he refused to work with. Netanyahu also could have made up the numbers by making peace with his estranged former protégé, the religious nationalist Naftali Bennett, and convincing Likud defectors in the New Hope party to return home. New Hope’s leader Gideon Saar maintained that his party was committed to ousting Netanyahu. Bennett, a multi-millionaire former tech entrepreneur, said Monday he could have endorsed Netanyahu to preserve right-wing governance but saw no path for the prime minister to clinch a viable coalition. Likud on Wednesday blasted Bennett for what it called “his refusal to form a right-wing government.” Bennett has long been viewed as a hardliner and enthusiastic supporter of Jewish settlement expansion on occupied Palestinian territory in the West Bank. But he sought to highlight his business and management credentials as pandemic closures ravaged Israel’s economy. Bennett has said his top priority is avoiding a fifth election and that he would work towards a unity government if Netanyahu could not form a coalition. Bennett may end up leading such a unity government, despite his Yamina party only controlling seven seats. Rivlin said he would contact political leaders on Wednesday morning “regarding the continuation of the process of forming a government.” He can assign a new 28-day mandate to another lawmaker, with opposition leader Yair Lapid the most likely choice after his centrist Yesh Atid party finished second in the vote. Lapid has confirmed that he offered Bennett the chance to serve first as premier in a rotational coalition, in the interest of ending Netanyahu’s tenure. “There is an historic opportunity. To break down the barriers at the heart of Israeli society. To unite religious and secular, left and right and center,” Lapid said Monday. “It’s time to choose. Between a unity government or ongoing division.” The former television presenter said last week’s stampede that killed 45 mainly ultra-Orthodox Jews at a religious festival was a consequence of Israel lacking a “functioning government.” He conceded that an ideologically divided coalition forged mainly through shared opposition against Netanyahu “won’t be perfect”, but would prioritise national interests. Rather than tap another lawmaker to form a government, the president could ask the Knesset to select a name, a move unlikely to break the deadlock that could accelerate Israel’s return to the polls. In a widely-criticised manouevre, Netanyahu and his allies have flirted with legislation to create a direct vote for prime minister, hoping he would emerge victorious in a divided field. Likud members made moves to advance such legislation as the prime minister’s mandate was expiring on Tuesday, but with little sign of success. FacebookTwitterLinkedinEMail
A suggestion to waive patent restrictions on Covid-19 vaccines has been rejected by Bill Gates, who said he doesn’t believe intellectual property has anything to do with the drawn-out global effort to rein in the pandemic.
Vaccines developed by pharmaceutical giants like Pfizer and Moderna enjoy global protection under the World Trade Organization (WHO). Considering the scarcity of the medicines, there have been increasing calls from countries like India and South Africa, international relief organizations and public figures to waive those protections so that poorer countries can get better access to the medicines.However, one of the most publicized figures in the global vaccination campaign, Bill Gates, apparently believes it’s a bad idea. When asked by Sky News’ Sophy Ridge if stripping intellectual property protections from vaccine recipes would be helpful, the founder of Microsoft responded with an emphatic “No.”“The thing that’s holding things back in this case is not intellectual property. It’s not like there’s some idle vaccine factory, with regulatory approval, that makes magically safe vaccines. You know, you’ve got to do the trial on these things. Every manufacturing process has to be looked at in a very careful way,” he explained.There are all sorts of issues around intellectual property having to do with medicines. But not in terms of how quickly we’ve been able to ramp up the volume here.Gates cited his foundation’s experience in helping to organize vaccine production in developing nations like India and said the fact that poor nations would likely have a chance to get supplies from rich ones as soon as they immunize their own populations was a success. “Typically, in global health it takes a decade between when a vaccine comes into the rich world and when it gets into the poor countries,” he noted.Gates speaks as if all the lives being lost in India are inevitable but eventually the West will help when in reality the US & UK are holding their feet on the neck of developing states by refusing to break TRIPS protections. It’s disgusting. https://t.co/sNdFanmIKH— Tara Van Ho (Dr) (@TaraVanHo) April 25, 2021Both Gates and his foundation are long-time defenders of intellectual property protections, and now critics are accusing Gates of deliberately wasting an opportunity to help reshape how intellectual property works for matters of greater public good. The Covid-19 ACT-Accelerator mechanism, backed by the Bill & Melinda Gates Foundation, has a stated goal of providing “equitable access” to anti-Covid tools – but it also respects the exclusive intellectual property rights. At the same time, Gates has apparently been snubbing the alternative solution, known as Covid-19 Technology Access Pool, or C-TAP, which would pool open-source technologies on how to deal with the pandemic.
Also on rt.com
Vaccine producers could have funded jabs for all of Africa, instead shareholder payouts & sluggish ‘charity’ efforts are priority
Big Pharma is quite happy with the status quo and has reportedly been engaged in its own effort to sink the waiver proposal. According to a Sunday report by the Financial Times, US pharmaceutical companies have been rattled by a recent WTO speech by Joe Biden’s top trade official Katherine Tai, in which she said Washington could “consider what modifications and reforms” can be applied to intellectual property rules.FT sources say that, in response, companies have been trying to convince the White House that China and Russia would benefit from patent exposure, using the proprietary US technologies “for other vaccines or even therapeutics for conditions such as cancer and heart problems in the future.”Think your friends would be interested? Share this story!